We are live on ! Find out more
FSA

Franklin Street Advisors Portfolio holdings

AUM $1.79B
1-Year Est. Return 28.1%
This Fund
S&P 500
This Quarter Est. Return
-11.87%
1 Year Est. Return
+28.1%
3 Year Est. Return
+112.88%
5 Year Est. Return
+150.28%
10 Year Est. Return
+636.48%
AUM
$632M
AUM Growth
-$107M
Cap. Flow
-$5M
Cap. Flow %
-0.79%
Top 10 Hldgs %
31.33%
Holding
177
New
8
Increased
50
Reduced
56
Closed
21

Top Sells

Rank Stock Value
1
CLB icon
Core Laboratories
CLB
+$9.07M
2
DD icon
DuPont de Nemours
DD
+$7.89M
3
GILD icon
Gilead Sciences
GILD
+$7.41M
4
SLB icon
SLB Ltd
SLB
+$5.88M
5
GS icon
Goldman Sachs
GS
+$4.38M

Sector Composition

Rank Sector Weight
1 Financials 17.4%
2 Technology 16.74%
3 Healthcare 16.39%
4 Consumer Discretionary 12.87%
5 Consumer Staples 11.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
151
Fortune Brands Innovations
FBIN
$6.22B
-85,604
Closed -$3.83M
FBNC icon
152
First Bancorp
FBNC
$2.64B
-10,144
Closed -$411K
GS icon
153
Goldman Sachs
GS
$303B
-19,510
Closed -$4.38M
INSM icon
154
Insmed
INSM
$21.3B
-16,000
Closed -$324K
KHC icon
155
Kraft Heinz
KHC
$31.3B
-6,137
Closed -$338K
NOC icon
156
Northrop Grumman
NOC
$77.9B
-780
Closed -$248K
PBYI icon
157
Puma Biotechnology
PBYI
$391M
-10,000
Closed -$459K
TJX icon
158
TJX Companies
TJX
$174B
-3,840
Closed -$215K
TXT icon
159
Textron
TXT
$14.9B
-3,585
Closed -$256K
UPS icon
160
United Parcel Service
UPS
$90.8B
-2,110
Closed -$246K
WMB icon
161
Williams Companies
WMB
$86.1B
-12,990
Closed -$353K
RDS.A
162
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-3,285
Closed -$224K
ECYT
163
DELISTED
Endocyte, Inc. Common Stock
ECYT
-22,425
Closed -$398K
CWBS
164
DELISTED
COMMONWEALTH BANKSHARES INC VA
CWBS
$0 ﹤0.01%
11,761
PDLI
165
DELISTED
PDL BioPharma, Inc.
PDLI
-20,000
Closed -$53K

Similar funds

Franklin Street Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Franklin Street Advisors held 177 positions worth $632M, down 14% from $739M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Franklin Street Advisors's Q4 2018 filing shows 8 new, 50 increased, 56 reduced and 21 closed positions. Its largest new stake was General Mills: 162,890 shares worth $6.34M. The largest sale was Core Laboratories, an estimated $9.07M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.

  • Franklin Street Advisors's largest Q4 2018 buy was General Mills: 162,890 shares worth $6.34M.
  • Franklin Street Advisors added most to Activision Blizzard in Q4 2018, an estimated $10M increase.
  • Franklin Street Advisors's biggest Q4 2018 reduction was DuPont de Nemours, cutting an estimated $7.89M.
  • Franklin Street Advisors fully exited Core Laboratories in Q4 2018, selling an estimated $9.07M.
  • Franklin Street Advisors's ten largest holdings make up 31% of its $632M portfolio in Q4 2018.
  • Franklin Street Advisors opened 8 new positions and closed 21 in Q4 2018.
  • Franklin Street Advisors's portfolio value fell 14% quarter-over-quarter to $632M.

Based on Franklin Street Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.